The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Detection of Galactomannan in Bronchoalveolar Lavage Fluid Samples of Patients at Risk for Invasive Pulmonary Aspergillosis: Analytical and Clinical Validity
Open accessAbstract
Invasive pulmonary aspergillosis (IPA) is frequent and often fatal in immunosuppressed patients. Timely diagnosis of IPA improves survival but is difficult to make. We examined the analytical and clinical validity of galactomannan (GM) testing of bronchoalveolar lavage (BAL) fluid in diagnosing IPA in a mixed population by retrospectively reviewing records of 251 consecutive at-risk patients for whom BAL fluid GM testing was ordered. The performance of the enzyme immunoassay was evaluated by using a range of index cutoffs to define positivity. Three samples were associated with proven IPA, 56 were associated with probable IPA, 63 were associated with possible invasive fungal disease (IFD), and 129 were associated with no IFD. Using a BAL fluid GM index of ≥0.8 (optimal optical density [OD] index cutoff identified by a receiver operating characteristic curve), the sensitivity in diagnosing proven and probable IPA was 86.4%, and the specificity was 90.7%. At this cutoff, positive and negative predictive values were 81% and 93.6%, respectively. However, an OD index value of ≥3.0 corresponded to a 100% specificity, thus ruling the disease in, irrespective of the pretest probability. Conversely, an OD index cutoff of <0.5 corresponded to a high sensitivity, virtually always ruling the disease out. For all values in between, the posttest probability of IPA depends largely on the prevalence of disease in the at-risk population and the likelihood ratio of the OD index value. Detection of GM in BAL fluid samples of patients at risk of IPA has an excellent diagnostic accuracy provided results are interpreted in parallel with clinico-radiological findings and pretest probabilities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Detection of galactomannan (a polysaccharide antigen found primarily in the cells walls of Aspergillus species) from bronchoalveolar lavage fluid (BALF), has been shown to be a useful and rapid tool for identification of IA in both immunocompromised and immunocompetent patients.58, 59, 60, 61”
From Co-infections in people with COVID-19: a systematic review and meta-analysis. (2020) · cites this paper as [58]
Citations
Cites
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Self-citationWalsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,705
Pulmonary aspergillosis: a clinical review
Kousha, M., Tadi, R., & Soubani, A. O. (2011) · European Respiratory Review · doi:10.1183/09059180.00001011 · Cited by 780
Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign
Greene, R. E., Schlamm, H. T., Oestmann, J. W., Stark, P., Durand, C. M., Lortholary, O., Wingard, J. R., Herbrecht, R., Ribaud, P., Patterson, T. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/509917 · Cited by 589
Upton, A., Kirby, K. A., Carpenter, P. A., Boeckh, M., & Marr, K. A. (2007) · Clinical Infectious Diseases · doi:10.1086/510592 · Cited by 510
Galactomannan in Bronchoalveolar Lavage Fluid
Meersseman, W., Lagrou, K., Maertens, J., Wilmer, A., Hermans, G., Vanderschueren, S., Spriet, I., Verbeken, E., & Van Wijngaerden, E. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200704-606oc · Cited by 496
Laboratory diagnosis of invasive aspergillosis
Hope, W., Walsh, T., & Denning, D. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70238-3 · Cited by 495
Galactomannan detection for invasive aspergillosis in immunocompromized patients
Leeflang, M., Debets-Ossenkopp, Y. J., Visser, C. E., Scholten, R. J. P. M., Hooft, L., Bijlmer, H. A., Reitsma, J. B., Bossuyt, P. M., & Vandenbroucke‐Grauls, C. M. J. E. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007394 · Cited by 364
Musher, B., Fredricks, D. N., Leisenring, W. M., Balajee, S. A., Smith, C. A., & Marr, K. A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5517-5522.2004 · Cited by 283
Maertens, J. A., Maertens, V., Theunissen, K., Meersseman, W., Meersseman, P., Meers, S., Verbeken, E. K., Verhoef, G. E. G., Eldere, J. V., & Lagrou, K. (2009) · Clinical Infectious Diseases · doi:10.1086/647935 · Cited by 250
Clancy, C. J., Jaber, R. A., Leather, H. L., Wingard, J. R., Staley, B. J., Wheat, L. J., Cline, C. L., Rand, K. H., Schain, D. C., Baz, M. A., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00077-07 · Cited by 230
Galactomannan detection for invasive aspergillosis in immunocompromised patients
Leeflang, M., Debets-Ossenkopp, Y. J., Wang, J., Visser, C. E., Scholten, R. J. P. M., Hooft, L., Bijlmer, H. A., Reitsma, J. B., Zhang, M., Bossuyt, P. M., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007394.pub2 · Cited by 228
Becker, M. J., Lugtenburg, E. J., Cornelissen, J. J., van der Schee, C., Hoogsteden, H. C., & de Marie, S. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04308.x · Cited by 216
Accuracy of BAL Galactomannan in Diagnosing Invasive Aspergillosis
Guo, Y., Chen, Y., Wang, K., Qin, S., Wu, C., & Kong, J. (2010) · CHEST Journal · doi:10.1378/chest.10-0488 · Cited by 197
Husain, S., Paterson, D. L., Studer, S. M., Crespo, M. M., Pilewski, J. M., Durkin, M., Wheat, L. J., Johnson, B. A., McLaughlin, L., Bentsen, C. G., et al. (2007) · Transplantation · doi:10.1097/01.tp.0000263992.41003.33 · Cited by 193
Sanguinetti, M., Posteraro, B., Pagano, L., Pagliari, G., Fianchi, L., Mele, L., Sorda, M. L., Franco, A., & Fadda, G. M. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3922-3925.2003 · Cited by 150
Luong, M., Clancy, C. J., Vadnerkar, A., Kwak, E. J., Silveira, F. P., Wissel, M., Grantham, K. J., Shields, R. K., Crespo, M. M., Pilewski, J. M., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir185 · Cited by 144
Detection and investigation of invasive mould disease
Cuenca‐Estrella, M., Bassetti, M., Lass‐Flörl, C., Racil, Z., Richardson, M. D., & Rogers, T. R. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq438 · Cited by 129
Maschmeyer, G., Beinert, T., Buchheidt, D., Cornely, O. A., Einsele, H., Heinz, W., Heußel, C. P., Kahl, C., Kiehl, M. G., Lorenz, J., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.05.001 · Cited by 125
Nucci, M., Nouér, S. A., Grazziutti, M., Kumar, N. S., Barlogie, B., & Anaissie, E. (2010) · Clinical Infectious Diseases · doi:10.1086/657065 · Cited by 112
Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications
Sherif, R. D., & Segal, B. H. (2010) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328337d6de · Cited by 108
Husain, S., Clancy, C. J., Nguyen, M. H., Swartzentruber, S., Leather, H. L., LeMonte, A. M., Durkin, M., Knox, K. S., Hage, C. A., Bentsen, C. G., et al. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00226-08 · Cited by 102
Nguyen, M. H., Jaber, R. A., Leather, H. L., Wingard, J. R., Staley, B. J., Wheat, L. J., Cline, C. L., Baz, M. A., Rand, K. H., & Clancy, C. J. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00716-07 · Cited by 97
Nguyen, M. H., Leather, H. L., Clancy, C. J., Cline, C. L., Jantz, M. A., Kulkarni, V., Wheat, L. J., & Wingard, J. R. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.11.013 · Cited by 83
Pasqualotto, A. C., Xavier, M. O., Sanchez, L. B., Costa, C. D. A. D. O., Schio, S. M., Camargo, S. M., Camargo, J. J., Sukiennik, T., & Severo, L. C. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e49bc1 · Cited by 78
Bergeron, A., Belle, A., Sulahian, A., Lacroix, C., Chevret, S., Raffoux, E., Arnulf, B., Socié, G., Ribaud, P., & Tazi, A. (2009) · CHEST Journal · doi:10.1378/chest.09-0701 · Cited by 78
Francesconi, A., Kasai, M., Petraitienė, R., Petraitis, V., Kelaher, A. M., Schaufele, R. L., Hope, W. W., M.S., Y. R. S., Bacher, J. D., & Walsh, T. J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.02693-05 · Cited by 76
Desai, R., Ross, L. A., & Hoffman, J. A. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31818f0934 · Cited by 71
Hage, C. A., Reynolds, J. M., Durkin, M., Wheat, L. J., & Knox, K. S. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01940-06 · Cited by 70
Park, S. Y., Lee, S., Choi, S., Sung, H., Kim, M., Choi, C., Hong, S., Oh, Y., Shim, T. S., Koh, Y., et al. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.08.014 · Cited by 68
Ráčil, Z., Kocmanová, I., Tošková, M., Burešová, L., Weinbergerová, B., Lengerová, M., Rolencová, M., Winterová, J., Hrnčířová, K., Volfová, P., et al. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.09.011 · Cited by 54
Ramos, E., Jiang, Y., Hachem, R. Y., Kassis, C., Kontoyiannis, D. P., & RAAD, I. I. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0290 · Cited by 52
Hsu, L. Y., Ding, Y., Phua, J., Koh, L., Chan, D. S. G., Khoo, K., & Tambyah, P. A. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-44 · Cited by 49
Optimizing management of invasive mould diseases
Agrawal, S., Hope, W. W., Sinkó, J., & Kibbler, C. C. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq441 · Cited by 48
Flagged first, then by citations
Cited by
Sorted by citations
Donnelly, J. P., Chen, S. C.-J., Kauffman, C. A., Steinbach, W. J., Baddley, J. W., Verweij, P. E., Clancy, C. J., Wingard, J. R., Lockhart, S. R., Groll, A. H., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1008 · Cited by 2,987
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Co-infections in people with COVID-19: a systematic review and meta-analysis.
Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.046 · Cited by 1,619
Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Molecular and Nonmolecular Diagnostic Methods for Invasive Fungal Infections
Arvanitis, M., Anagnostou, T., Fuchs, B. B., Caliendo, A. M., & Mylonakis, E. E. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00091-13 · Cited by 367
Metadata
- Authors
- D'Haese, J., Theunissen, K., Vermeulen, E., Schoemans, H., De Vlieger, G., Lammertijn, L., Meersseman, P., Meersseman, W., Lagrou, K., & Maertens, J.
- Affiliations
- Universitair Ziekenhuis Leuven (BE)
- Department of Hematology, Acute Leukemia and Stem Cell Transplantation Unit, Medical Intensive Care Unit, Universitaire Ziekenhuizen Leuven, Campus Gasthuisberg, Catholic University of Leuven, Leuven, Belgium
- Department of General Internal Medicine, Medical Intensive Care Unit, Universitaire Ziekenhuizen Leuven, Campus Gasthuisberg, Catholic University of Leuven, Leuven, Belgium
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2012-04
- Volume
- 50
- Issue
- 4
- Pages
- 1258-1263
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC3318563
- OpenAlex
- W2069266003
- Cited by
- 186
- References
- 34
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 11 · 2023: 20 · 2022: 12 · 2021: 12 · 2020: 14 · 2019: 15 · 2018: 11 · 2017: 20 · 2016: 10 · 2015: 15 · 2014: 16 · 2013: 10 · 2012: 5
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- invasive pulmonary aspergillosis, galactomannan, bronchoalveolar lavage fluid, enzyme immunoassay, diagnostic accuracy, sensitivity and specificity, predictive value, likelihood ratios, pretest probability, invasive fungal infections, immunocompromised patients
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Bronchoalveolar Lavage Fluid, Female, Galactose, Humans, Male, Mannans, Middle Aged, Retrospective Studies, ROC Curve, Immunocompromised Host, Invasive Pulmonary Aspergillosis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review